Analyze NNVC

ShareShare on WhatsApp Share on Facebook Share on X

Equity Research · Deep diveIT-2026-NNVC · 2026-07-30

NanoViricides, Inc. (NNVC)

HealthcareBiotechnologyNYSE AmericanMarket cap $39.27M

$1.54

-4.35%

Analyst-style PDF, emailed within minutes

62/100

Positive bias

Automated weighted score · not a recommendation

Price source: Yahoo (yfinance) · as of 2026-07-29 · Data: Yahoo · SEC EDGAR · FINRA · Wikidata

About the company

Market cap

$39.27M

P/E

—

Beta

1.67

Employees

Sector: HealthcareIndustry: BiotechnologyExchange: NYSE AmericanCountry: United States Website

What the company does

NanoViricides, Inc., a clinical stage nano-biopharmaceutical company, discovers, develops, and commercializes drugs to combat viral infections. The company's product portfolio includes NV-387 drug candidate developed for RSV and influenza indications and has completed phase 1a/1b human clinical trial for the evaluation of safety and tolerability; NV-387 as an active ingredient of drug product formulations for the treatment of COVID infections comprising NV-CoV-2 Oral Syrup and NV-CoV-2 Oral Gummies developed for the treatment of COVID infection, a semi-solid fixed-dose form, which are in phase 1a/1b human clinical trials for enabling body-weight-based dose titration as is required for pediatric treatments. It also offers NV-387 Solution for injection, infusion, and inhalation to treat severe cases that are not hospitalized and carried out by an injection; and injectable solution that delivered directly into the lungs as a fog created using portable battery operated nebulizer devices, which enables action at infection by a respiratory virus, such as coronaviruses, RSV, influenzas, human meta-pneumovirus, certain adenoviruses, and other infections, that can lead to severe pneumonia. In addition, the company develops NV-HHV-1, a skin cream for the treatment of Shingles rash, which has completed non-clinical pharmacology studies; oral drug with NV-HHV-1 as the active ingredient for the treatment of HSV-1 cold sores and HSV-2 genital ulcers; and other drug candidates in HIVCide program for the treatment of Dengue and Ebola virus, as well as provides Nanoviricide platform technology to treat various types of viruses. NanoViricides, Inc. was incorporated in 2005 and is headquartered in Shelton, Connecticut.

Day range

$1.52$1.62

52-week range

$0.85$2.23

Price alert on NNVC

Get an in-app and mobile alert every time NNVC crosses a price you set.

The technical signal compass

Sign up free and build your own trading bot with full backtesting. Live bots, real-time alerts and the bot gallery — with a Pro subscription.

Free sign-up

NanoViricides, Inc. (NNVC) is trading around $1.54 (-4.35% on the last session). Its 52-week range runs from $0.85 to $2.23. Technically: 5 buy signals, 2 sell and 5 neutral. It belongs to the Healthcare sector (Biotechnology) and a 39M$ market cap. Data sourced from Yahoo (yfinance) as of 2026-07-29. This is data analysis only, not advice or a recommendation.

NNVC stock FAQ

What is NNVC's current price?

NNVC is trading around $1.54 (-4.35%), as of 2026-07-29 per Yahoo (yfinance).

What is NNVC's 52-week price range?

Over the last 52 weeks NNVC ranged between a $0.85 low and a $2.23 high.

Which sector does NNVC belong to?

NNVC belongs to the Healthcare sector, Biotechnology industry.

Disclosure & disclaimer: All information, scores, signals and trade plans on this site are produced by an automated algorithmic system and are based on technical and quantitative data only. They do not constitute investment advice, investment marketing or a recommendation to act, and are not a substitute for personal advice from a licensed professional that accounts for your needs and circumstances. We are not investment advisors. Trading securities involves substantial risk, up to the loss of your entire investment; every decision and action is your sole responsibility. i-trade and its operators bear no liability for any direct or indirect damage arising from reliance on this information.

0 買買 0 $ ▼ ↑ 0 % ₿ ₿ % 0 ↑ ▼ $ 0 買買 0 $ ▼# € € # ◇ 1 ▲ ↓ 売 1 1 売 ↓ ▲ 1 ◇ # € € # ◇ 1買 0 0 買 ↑ % 0 ▼ ₿ $ $ ₿ ▼ 0 % ↑ 買 0 0 買 ↑ %€ ↓ ↓ € ▲ 売 # 1 1 ◇ ◇ 1 1 # 売 ▲ € ↓ ↓ € ▲ 売0 ▼ ▼ 0 0 ₿ 買 % $ ↑ ↑ $ % 買 ₿ 0 0 ▼ ▼ 0 0 ₿↓ 1 1 ↓ # 1 € 売 ◇ ▲ ▲ ◇ 売 € 1 # ↓ 1 1 ↓ # 1▼ % % ▼ 買 $ 0 ₿ ↑ 0 0 ↑ ₿ 0 $ 買 ▼ % % ▼ 買 $1 売売 1 € ◇ ↓ 1 ▲ # # ▲ 1 ↓ ◇ € 1 売売 1 € ◇% ₿ ₿ % 0 ↑ ▼ $ 0 買買 0 $ ▼ ↑ 0 % ₿ ₿ % 0 ↑売 1 1 売 ↓ ▲ 1 ◇ # € € # ◇ 1 ▲ ↓ 売 1 1 売 ↓ ▲₿ $ $ ₿ ▼ 0 % ↑ 買 0 0 買 ↑ % 0 ▼ ₿ $ $ ₿ ▼ 01 ◇ ◇ 1 1 # 売 ▲ € ↓ ↓ € ▲ 売 # 1 1 ◇ ◇ 1 1 #$ ↑ ↑ $ % 買 ₿ 0 0 ▼ ▼ 0 0 ₿ 買 % $ ↑ ↑ $ % 買◇ ▲ ▲ ◇ 売 € 1 # ↓ 1 1 ↓ # 1 € 売 ◇ ▲ ▲ ◇ 売 €↑ 0 0 ↑ ₿ 0 $ 買 ▼ % % ▼ 買 $ 0 ₿ ↑ 0 0 ↑ ₿ 0▲ # # ▲ 1 ↓ ◇ € 1 売売 1 € ◇ ↓ 1 ▲ # # ▲ 1 ↓0 買買 0 $ ▼ ↑ 0 % ₿ ₿ % 0 ↑ ▼ $ 0 買買 0 $ ▼# € € # ◇ 1 ▲ ↓ 売 1 1 売 ↓ ▲ 1 ◇ # € € # ◇ 1

Building the strategy

NNVC stock FAQ

What is NNVC's current price?

NNVC is trading around $1.54 (-4.35%), as of 2026-07-29 per Yahoo (yfinance).

What is NNVC's 52-week price range?

Over the last 52 weeks NNVC ranged between a $0.85 low and a $2.23 high.

Which sector does NNVC belong to?

NNVC belongs to the Healthcare sector, Biotechnology industry.

Analyze NNVC

NanoViricides, Inc. (NNVC)

About the company

The technical signal compass

NNVC stock FAQ

NanoViricides, Inc. (NNVC)

About the company

The technical signal compass

NNVC stock FAQ

Income statement analysis

Institutional & insider data

Full analyst coverage

NNVC · Chart

Support & resistance